Literature DB >> 15741133

The classification of status epilepticus.

Simon Shorvon.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15741133

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN： 1294-9361            Impact factor:   1.819


× No keyword cloud information.
  6 in total

Review 1.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

2.  Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity.

Authors:  Nicola Marchi; Qingshan Teng; Chaitali Ghosh; Qingyuan Fan; Minh T Nguyen; Nirav K Desai; Harpreet Bawa; Peter Rasmussen; Thomas K Masaryk; Damir Janigro
Journal:  Brain Res       Date:  2010-06-27       Impact factor: 3.252

3.  Cortical regional hyperperfusion in nonconvulsive status epilepticus measured by dynamic brain perfusion CT.

Authors:  M Hauf; J Slotboom; A Nirkko; F von Bredow; C Ozdoba; R Wiest
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

Review 4.  [Management of refractory status epilepticus from a neurologic and neuropediatric perspective].

Authors:  B Pohlmann-Eden; U Stephani; I Krägeloh-Mann; B Schmitt; U Brandl; M Holtkamp
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

Review 5.  Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.

Authors:  Helga E de Vries; Gijs Kooij; Dan Frenkel; Spiros Georgopoulos; Alon Monsonego; Damir Janigro
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

Review 6.  Antiepileptic Drug Therapy for Status Epilepticus.

Authors:  Daeyoung Kim; Jae Moon Kim; Yong Won Cho; Kwang Ik Yang; Dong Wook Kim; Soon Tae Lee; Young Joo No; Jong Geun Seo; Jung Ick Byun; Kyung Wook Kang; Keun Tae Kim
Journal:  J Clin Neurol       Date:  2021-01       Impact factor: 3.077
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.